Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,828 shares at $35.10 ($64K) on 2014-08-04, disclosed to the SEC on 2014-08-05.
Scheduled sale ($64k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |